for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

VIVA Biotech Holdings

1873.HK

Latest Trade

4.87HKD

Change

-0.10(-2.01%)

Volume

3,528,500

Today's Range

4.87

 - 

5.07

52 Week Range

4.68

 - 

11.64

As of on the Hong Kong Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
4.97
Open
4.97
Volume
3,528,500
3M AVG Volume
91.26
Today's High
5.07
Today's Low
4.87
52 Week High
11.64
52 Week Low
4.68
Shares Out (MIL)
1,925.64
Market Cap (MIL)
9,377.89
Forward P/E
17.03
Dividend (Yield %)
0.21

Next Event

VIVA Biotech Holdings Annual Shareholders Meeting

Latest Developments

More

Viva Biotech Holdings Posts HY Net Profit RMB 95.8 MLN

VIVA Biotech Says Ban Yan To Be Named Chair Of Zhejiang Langhua Pharmaceutical

Viva Biotech Holdings Sees A Net Profit Of No Less Than RMB85 Million For Six Months

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About VIVA Biotech Holdings

VIVA Biotech Holdings is a China-based investment holding company. The Company is principally engaged in the provision of the structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide for their pre-clinical stage innovative drug development. The Company’s core technologies include structure-based drug discovery (SBDD) platform, fragment-based drug discovery (FBDD) platform, affinity selection mass spectrometry (ASMS) screening platform and membrane protein targeted drug discovery platform. The Company operates its businesses mainly in the United States, China, Europe and other regions.

Industry

Biotechnology & Drugs

Key Stats

1.00 mean rating - 2 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2019

0.3K

2020

0.7K

2021(E)

2.3K
EPS (CNY)

2019

0.176

2020

-0.250

2021(E)

0.230
Price To Earnings (TTM)
31.52
Price To Sales (TTM)
5.03
Price To Book (MRQ)
2.01
Price To Cash Flow (TTM)
20.80
Total Debt To Equity (MRQ)
62.70
LT Debt To Equity (MRQ)
57.11
Return on Investment (TTM)
4.91
Return on Equity (TTM)
4.41

Latest News

Latest News

BRIEF-Viva Biotech To Place Aggregate Of 130 Mln Placing Shares At HK$8.15 Per Placing Share

* TO PLACE AGGREGATE OF 130 MILLION PLACING SHARES TO NOT LESS THAN 6 PLACEES AT HK$8.15 PER PLACING SHARE Source text for Eikon: Further company coverage:

BRIEF-Viva Biotech Says Trading In Shares & Guaranteed Convertible Bonds Halted

* TRADING IN SHARES & GUARANTEED CONVERTIBLE BONDS HALTED WITH EFFECT FROM 9:00 A.M. ON JULY 3 Source text for Eikon: Further company coverage:

BRIEF-Viva Biotech Says Entered A Bid For Land Use Right Of A Property At Shanghai

* ENTERED A BID FOR LAND USE RIGHT OF A PROPERTY AT SHANGHAI BY WAY OF INTERNET AUCTION

BRIEF-Viva Biotech Says Ninhua Group & Others Accepted Letter Delivered By Viva Biotech Shanghai

* VIVA BIOTECH HOLDINGS-NINHUA GROUP, NUOBAI INVESTMENTS, ZHINING INVESTMENTS & INDIVIDUALS ACCEPTED LETTER DELIVERED BY VIVA BIOTECH SHANGHAI

BRIEF-Viva Biotech Holdings Enters Contraction Contract With Sichuan Chunqiu

* SICHUAN CHUNQIU TO UNDERTAKE CONSTRUCTION WORK FOR VIVA BIOTECH NEW DRUG INCUBATION CENTER

BRIEF-Viva Biotech Holdings Says Deloitte Touche Tohmatsu Will Retire As Auditor

* RESOLVED ERNST & YOUNG BE TO BE APPOINTED AS AUDITOR Source text for Eikon: Further company coverage:

BRIEF-Viva Biotech Announces Amendment Of Dividend Policy

* APPROVED AMENDMENT OF DIVIDEND POLICY BY INCREASING MAX DIVIDEND DISTRIBUTION FOR ANY FY FROM 30% TO 40% OF ANY DISTRIBUTABLE PROFIT Source text for Eikon: Further company coverage:

BRIEF-Viva Biotech Holdings Posts FY Profit RMB 265.9 Mln

* AS OF MARCH 30, COVID-19 OUTBREAK HAS NOT RESULTED IN ANY SIGNIFICANT IMPACT TO GROUP'S OPERATION Source text for Eikon: Further company coverage:

BRIEF-Viva Biotech Holdings Expects Revenue Of Group For Year Will Increase By More Than 50%

* EXPECTED THAT REVENUE OF GROUP FOR YEAR WILL INCREASE BY MORE THAN 50%

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up